(Q34533863)

2 August 2017

1 reference

title

Levetiracetam: a different approach to the pharmacotherapy of epilepsy (English)

1 reference

2 August 2017

0 references

1 reference

Timothy E Welty

1

1 reference

2 August 2017

Barry E Gidal

series ordinal

2

1 reference

2 August 2017

David M Ficker

series ordinal

3

1 reference

2 August 2017

Michael D Privitera

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Annals of Pharmacotherapy

2 August 2017

published in

1 reference

2 August 2017

volume

36

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

296-304

1 reference

Pharmacokinetic profile of levetiracetam: toward ideal characteristics

2 August 2017

cites work

1 reference

Piracetam and levetiracetam, two pyrrolidone derivatives, exert antidystonic activity in a hamster model of paroxysmal dystonia

21 January 2018

1 reference

Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy

21 January 2018

1 reference

The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata.

21 January 2018

1 reference

Neurochemical studies with the novel anticonvulsant levetiracetam in mouse brain

21 January 2018

1 reference

Inhibition by levetiracetam of a non-GABAA receptor-associated epileptiform effect of bicuculline in rat hippocampus

21 January 2018

1 reference

Therapeutic safety monitoring: what to look for and when to look for it.

21 January 2018

1 reference

The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes

21 January 2018

1 reference

Blood and cerebrospinal fluid pharmacokinetics of the novel anticonvulsant levetiracetam (ucb L059) in the rat.

21 January 2018

1 reference

Absence of Pharmacokinetic Drug Interaction of Levetiracetam with Phenytoin in Patients with Epilepsy Determined by New Technique

21 January 2018

1 reference

A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.

21 January 2018

1 reference

Effect of levetiracetam on epilepsy-related quality of life. N132 Study Group.

21 January 2018

1 reference

Efficacy and tolerability study of ucb L059 in patients with refractory epilepsy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1A032

1 reference

2 August 2017

1 reference